NOGUCHI Masanori 野口正典

… Alternative Names

野口正典ノグチマサノリ

Less

Researcher Number	10140691
Affiliation (Current)	2025: 久留米大学, 付置研究所, 教授
Affiliation (based on the past Project Information) *help	2015 – 2017: 久留米大学, 付置研究所, 教授 2015 – 2016: 久留米大学, 先端がん治療研究センター, 教授 2014: 久留米大学, 先端癌治療研究センター, 教授 2010 – 2012: 久留米大学, 先端癌治療研究センター, 教授 2007 – 2008: Kurume University, Sch. Med, Assistant Professor … More 2006: 久留米大学, 医学部, 助教授 2003 – 2004: 久留米大学, 医学部, 助教授 1998: 久留米大, 医学部, 講師 Less
Review Section/Research Field	Principal Investigator Urology / Urology Except Principal Investigator Urology / Living organism molecular science / Tumor diagnostics
Keywords	Principal Investigator ペプチドワクチン療法 / テーラーメイド / 再燃前立腺癌 / ESTRAMUSTINE / IMMUNOTERAPY / PEPTIDE VACCINATION / PRSTATE CANCER / エストラムスチン / 免疫療法 / バイオマーカー … More / ゲノム解析 / 遺伝子発現 / がんワクチン / 前立腺がん / HLA-A3ファミリー / 汎HLA / ペプチドワクチン / バイオテクノロジー / 免疫学 / 癌 … More Except Principal Investigator バイオマーカー / サイトカイン / 生存率 / 尿路上皮がん / がんペプチドワクチン / immunology / biotechnology / allergy / virus / cancer / 免疫学 / バイオテクノロジー / 癌 / ウィルス / アレルギー・ぜんそく / SNPｓ / がん予後予測 / 血漿 / がん / SNPs / ペプチドワクチン / ハプトグロビン Less

Biomarkers of personalized peptide vaccination for metastatic upper tract urothelial carcinoma
- Principal Investigator
  
  Suekane Shigetaka
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
Haptoglobin polymorphism as a prognostic biomarker for peptide vaccine efficacy in cancer patients
- Principal Investigator
  
  Shichijo Shigeki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor diagnostics
- Research Institution
  Kurume University
Genomic and epigenetic analysis for immune responses in patients with prostate cancerPrincipal Investigator
- Principal Investigator
  
  NOGUCHI Masanori
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
Basic and clinical research on pan-HLA peptide vaccination for prostate cancerPrincipal Investigator
- Principal Investigator
  
  NOGUCHI Masanori
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Living organism molecular science
- Research Institution
  Kurume University
BACICALAND CLINICAL RESERCH OF PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCERPrincipal Investigator
- Principal Investigator
  
  NOGUCHI Masanori
- Project Period (FY)
  2003 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  KURUME UNIVERSITY
泌尿器系悪性腫瘍に発現する癌拒絶抗原の同定と臨床応用Principal Investigator
- Principal Investigator
  
  野口正典
- Project Period (FY)
  1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University

All 2017 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Other

All Journal Article Presentation Patent

[Journal Article] Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.2017
- Author(s)
  Suekane S, Ueda K, Nishihara K, Sasada T, Yamashita T, Koga N, Yutani S, Shichijo S, Itoh K, Igawa T, Noguchi M.
- Journal Title
  
  Cancer Sci.
  
  Volume: 108 Issue: 12 Pages: 2430-2437
- DOI
  10.1111/cas.13404
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-15K10614, KAKENHI-PROJECT-16K15601
[Journal Article] Next-generation peptide vaccines for advanced cancer.2013
- Author(s)
  Yamada A, Sasada T, Noguchi M, Itoh K.
- Journal Title
  
  Cancer Sci
  
  Volume: 104 Pages: 15-21
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.2013
- Author(s)
  Noguchi M, Sasada T, Itoh K.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 62 Pages: 919-929
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012
- Author(s)
  Komatsu N, Noguchi M, et al
- Journal Title
  
  Cancer
  
  Volume: (In press) Issue: 12 Pages: 3208-3221
- DOI
  10.1002/cncr.26636
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.2012
- Author(s)
  Komatsu N, Matsueda S, Tashiro K, IojiT, Shichijo S, Noguchi M, Suekane S, Moriya F, Matsuoka K, Kuhara S, Itoh K, Sasada T.
- Journal Title
  
  Cancer
  
  Volume: 15 Pages: 3208-3221
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] A novel immunotherapeutic approach for advanced cancer.2012
- Author(s)
  Sasada T, Noguchi M, Yamada A, Itoh K. Personalized peptide vaccination
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 8(9) Pages: 1309-1313
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Personalized peptide vaccination in patients with refractory non-small cell lung cancer.2012
- Author(s)
  Yoshiyama K, Terazaki Y, Matsueda S, Shichijo S, Noguchi M, Yamada A, Mine T, Ioji T, Itoh K, Shirouzu K, Sasada T, Takamori S.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 40 Pages: 1492-1500
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer.2012
- Author(s)
  Sasada T, Noguchi M, et al.
- Journal Title
  
  Hum Vaccin Immunother
  
  Volume: 8 Issue: 9 Pages: 1309-1313
- DOI
  10.4161/hv.20988
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer2011
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Prostate
  
  Volume: 71 Pages: 470-479
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.2011
- Author(s)
  Matsumoto K, Noguchi M, Satoh T, Tabata K, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
- Journal Title
  
  BJU Int
  
  Volume: 108 Pages: 831-838
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination withlow-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.2011
- Author(s)
  Noguchi M, Uemura H, Naito S, Akaza H, Yamada A, Itoh K.
- Journal Title
  
  Prostate
  
  Volume: 71 Pages: 470-9
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin2011
- Author(s)
  Matsumoto K, Noguchi M, et al
- Journal Title
  
  BJU Int
  
  Volume: 108 Pages: 831-838
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.2011
- Author(s)
  Noguchi M, Moriya F, Suekane S, Matsuoka K, Arai G, Matsueda S, Sasada T, Akira Yamada A, Itoh K.
- Journal Title
  
  Prostate
  
  Volume: 71 Pages: 470-479
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24,-A31 and -A33)-positive patients with advanced cancer.2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
- Journal Title
  
  Experimental and therapeutic medicine
  
  Volume: 2 Pages: 109-117
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.2011
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh Uhi, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 12 Pages: 1266-79
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy2011
- Author(s)
  Noguchi M, et al
- Journal Title
  
  Prostate
  
  Volume: 71 Issue: 8 Pages: 470-479
- DOI
  10.1002/pros.21485
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination2010
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 10 Pages: 1266-1279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Capability of SART3109-118 peptide to induce cytotoxic T-lymphocytes from prostate cancer patients with HLA class .-A11, -A31, and -A33 alleles.2009
- Author(s)
  Mohamed ER, Naito M, Terasaki Y, Niu Y, Gohara S, Komatsu N, Shichijo S, Itoh K, Noguchi M
- Journal Title
  
  Int J Oncol 34 (peer review)
  
  Pages: 529-536
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Capability of SART3_<109-118> peptide to induce cytotoxic T-lymphocytes from prostate cancer patients with HLA class I-A11, -A31, and -A33 alleles.2009
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Int J Oncol 34
  
  Pages: 529-536
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.2008
- Author(s)
  Naito M, Itoh K, Komatsu N, Yamashita Y, Shirakusa T, Yamada A, Moriya F, Ayatuka H, Mohamed ES, Matsuoka K, Noguchi M
- Journal Title
  
  Prostate 68 (peer review)
  
  Pages: 1753-1762
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] A randomized clinical trial of suspension technique for improving early recovery of urinary continence after radical retropubic prostatectomy.2008
- Author(s)
  Noguchi M, Kakuma T, Suekane S, Nakashima O, Mohamed ER, Matsuoka K
- Journal Title
  
  BJU Int 102 (peer review)
  
  Pages: 958-963
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] 癌特異的免疫療法を基盤としたホルモン不応性再燃前立腺癌に対する集学的治療2008
- Author(s)
  野口正典, 他
- Journal Title
  
  西日泌尿 70
  
  Pages: 230-235
- NAID
  10026145799
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.2008
- Author(s)
  Noguchi M, et al
- Journal Title
  
  Prostate 68
  
  Pages: 1753-1762
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Immunological evaluation of neoadjuvant peptide vaccination befbre radical prostatectomy for patients with localized prostate cancer2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  Prostate 67
  
  Pages: 933-942
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Differential levels of human leukocyte antigen-class I,multidrug-resistance 1,and androgen receptor expressions in untreated prostate cancer ceIls:the robustness of prostate cancer2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  Oncology Reports 18
  
  Pages: 343-346
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients:An analysis of prognostic factors in the treatment2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients:an analysis of prognostic factors in the treatment2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of target antigens in specific immunotherapy for renal cellcarcinoma2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  J Urol 177
  
  Pages: 1157-1162
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.2007
- Author(s)
  Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matuoka K
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007
- Author(s)
  Naito N, Yoshihiro K, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  Br J Cancer 97 (peer review)
  
  Pages: 1648-1654
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Combination therapy of personalized peptide vaccination with low-doseestramustine phosphate for metastatic hormone refractory prostate cancer patients: an analsis of pronostic factors in the treatment2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Matsueda S, Takedatsu H, Sasada T, Azuma K, Ishihara Y, Komohara Y, Noguchi M, Shichijo S, Itoh K, Harada M
- Journal Title
  
  J Immunother 30
  
  Pages: 274-281
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of SART3-derived peptides having the potential to hlduce cancer-reactive cytotoxic T lymphocytes from prostate callcer patients with HLA-A3 supertype alleles2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  Cancer Immunol Immun 56
  
  Pages: 689-698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Minami T, Matsueda S, Takedatsu H, Tanaka M, Noguchi M, Uemura H, Itoh K, Harada M
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 689-698
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New Peptide Vaccine Candidates for Epithelial Cancer Patients with HLA-A3 Suee Alleles2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  J Immunother 30
  
  Pages: 274-281
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Expression of APOBEC3G in kidney cells2007
- Author(s)
  Noguchi M, et. al.
- Journal Title
  
  Tissue antigens 69
  
  Pages: 95-98
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19591877
[Journal Article] Identification of Lek-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007
- Author(s)
  Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Immunological evaluation of individualized peptide vaccination with low dose of estramustine for HLA-A24^+ HRPC patients.2005
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Prostate 63
  
  Pages: 1-12
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Immunological evaluation of individualized peptide vaccination with low dose of estramustine for HLA-A24^+ HRPC patients.2005
- Author(s)
  Noguchi M
- Journal Title
  
  Prostate 63
  
  Pages: 1-12
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Immunological Monitoring During Combination of Patient-Oriented Peptide Vaccination and Estramustine Phosphate in Patients With Metastatic Hormone Refractory Prostate Cancer.2004
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Prostate 60
  
  Pages: 32-45
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.2004
- Author(s)
  Harada M, Noguchi M, et al.
- Journal Title
  
  Oncology Reports 12
  
  Pages: 601-607
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Humoral resposes to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-ezisting peptide-specific cellular resposes.2004
- Author(s)
  Mine T, Noguchi M, et al.
- Journal Title
  
  Clin Cancer Res 10
  
  Pages: 929-967
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Humoral resposes to peptides correlate with overall survival in advanced cancer patients vaccinated with pepitides based on pre-ezisting peptide-specific cellular resposes.2004
- Author(s)
  Mine T, Noguchi M, et al.
- Journal Title
  
  Clin Cancer Res 10
  
  Pages: 929-967
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2^+ prostate cancer patients.2004
- Author(s)
  Yao A, Noguchi M, et al.
- Journal Title
  
  Prostate 62
  
  Pages: 233-242
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Identification of polycomb group protein enchanter of zeste homolog 2 (EZH2)-derived peptide immunogenic in HLA-A24+ prostate cancer patients.2004
- Author(s)
  Ogata R, Noguchi M, et al.
- Journal Title
  
  Prostate 60
  
  Pages: 983-988
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] A prostate stem cell antigen-derived peptide immunogenic in HLA-A24+ prostate cancer patients.2004
- Author(s)
  Matsueda S, Noguchi M
- Journal Title
  
  Prostate 60
  
  Pages: 205-213
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Chemohormonal Therapy As Primary Treatment For Metastatic Prostate Cancer : A Randomized Study Of Estramustine Phosphate Plus LHRH Agonist Versus Flutamide Plus Luteinizing Hormone-Releasing Hormone Agonist.2004
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Int J Urol 11
  
  Pages: 103-109
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Identification of polycomb group protein enchancer of zeste homolog 2(EZH2)-derived peptide immunogenic in HLA-A24+ prostate cancer patients.2004
- Author(s)
  Ogata R, Noguchi M, et al.
- Journal Title
  
  Prostate 60
  
  Pages: 273-296
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24+ prostate cancer patients.2004
- Author(s)
  Yao A, Noguchi M, et al.
- Journal Title
  
  Br J Cancer 91
  
  Pages: 287-295
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Early catheter removal 3 days after radical retropubic prostatectomy.2004
- Author(s)
  Noguchi M
- Journal Title
  
  Int J Urol 11
  
  Pages: 983-988
- NAID
  10014044474
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.2004
- Author(s)
  Yao A, Noguchi M, et al.
- Journal Title
  
  Prostate 62
  
  Pages: 233-242
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] A prostate stem cell antigen-derived peptide immunogenic in HLA-A24+ prostate cancer patients.2004
- Author(s)
  Matsueda S, Noguchi M, et al.
- Journal Title
  
  Prostate 60
  
  Pages: 205-213
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Early catheter removal 3 days after radical retropubic prostatectomy.2004
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Int J Urol 11
  
  Pages: 983-988
- NAID
  10014044474
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with matastatic hormone-refractory prostate cancer.2004
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Cancer Sci 95
  
  Pages: 77-84
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2+ patients with hormone-refractory prostate cancer.2004
- Author(s)
  Matsueda S, Noguchi M, et al.
- Journal Title
  
  Cancer Immunol Immunother 53
  
  Pages: 479-489
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Journal Article] Chemohormonal Therapy As Primary Treatment For Metastatic Prostate Cancer : A Randomized Study Of Estramustine Phosphate Plus LHRH Agonist Versus Flutamide Plus LHRH Agonist.2004
- Author(s)
  Noguchi M, et al.
- Journal Title
  
  Int J Urol 11
  
  Pages: 103-109
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Patent] がんの検査用試薬及び検査方法2012
- Inventor(s)
  伊東恭悟、野口正典、他
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Rights Type
  特許
- Filing Date
  2012-06-22
- Overseas
- Data Source
  KAKENHI-PROJECT-22591782
[Patent] 特異免疫機能診断キット2011
- Inventor(s)
  伊東恭悟、野口正典、他
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2011-06-24
- Overseas
- Data Source
  KAKENHI-PROJECT-22591782
[Patent] 癌患者に対する免疫療法の治療効果および/または免疫療法後の予後の予測方法、ならびに該方法に用いる遺伝子セットおよびキット2010
- Inventor(s)
  伊東恭悟、野口正典、他
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2010-09-30
- Overseas
- Data Source
  KAKENHI-PROJECT-22591782
[Patent] がんの検査用試薬及び検査方法2010
- Inventor(s)
  伊東恭悟、野口正典
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2010-06-22
- Overseas
- Data Source
  KAKENHI-PROJECT-22591782
[Patent] HLA-A3スーパータイプの患者に対するがんワクチンのためのLck-由来ペプチドの同定2007
- Inventor(s)
  伊東恭悟, 野口正典, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2007-212179
- Filing Date
  2007-08-16
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] HLA-A3スーパータイプの患者に対するがんワクチンのためのLck-由来ペプチドの同定2007
- Inventor(s)
  伊東恭悟、野口正典、原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2007-212179
- Filing Date
  2007-08-16
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] HLA-A3スーパータイプアレル分子陽性前立腺癌患者に対する癌ワクチン候補となる前立腺関連蛋白由来ペプチド2006
- Inventor(s)
  伊藤恭悟, 原田守, 野口正典
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-06-22
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] ペプチドワクチン投与およびエストラムスチン処置の併用療法2004
- Inventor(s)
  野口正典, 伊東恭悟
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2004-318161
- Filing Date
  2004-11-01
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15591721
[Presentation] Delayed PSA responses in personalized peptide vaccination for castration-resistant prostate cancer2012
- Author(s)
  Noguchi M, et al.
- Organizer
  Phase II study 2012 AUA Annual Meeting
- Place of Presentation
  Atolanta, USA
- Year and Date
  2012-05-20
- Data Source
  KAKENHI-PROJECT-22591782
[Presentation] Open-label phase II study evaluating the efficacy and safety of personalized peptide vaccination (PPV) in patients with castration-resistant prostate cancer(CRPC)2011
- Author(s)
  Noguchi M, et al.
- Organizer
  2011 AUA Annual Meeting
- Place of Presentation
  Washington DC, USA
- Year and Date
  2011-05-17
- Data Source
  KAKENHI-PROJECT-22591782
[Presentation] 他去勢抵抗性前立腺がんに対するペプチドワクチン療法の予後規定バイオマーカー:中間解析2011
- Author(s)
  野口正典、
- Organizer
  第49回日本癌治療学会学術集会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-29
- Data Source
  KAKENHI-PROJECT-22591782
[Presentation] Open-label phase II study evaluating the efficacy and safety of personalized peptide vaccination (PPV) in patients with castration-resistant prostate cancer (CRPC)2011
- Author(s)
  Noguchi M, et al
- Organizer
  2011 AUA Annual Meeting
- Place of Presentation
  Washington DC, USA
- Year and Date
  2011-05-17
- Data Source
  KAKENHI-PROJECT-22591782
[Presentation] 進行癌に対するがんペプチドワクチン療法における免疫学的バイオマーカーの検討2010
- Author(s)
  野口正典
- Organizer
  第48回日本癌治療学会
- Place of Presentation
  京都国際会議場(京都)
- Year and Date
  2010-10-29
- Data Source
  KAKENHI-PROJECT-22591782
[Presentation] Immunological and clinical effects of personalized peptide vaccine for HLA-A2 positive patients with advanced cancer.2008
- Author(s)
  Noguchi M, Todo S, Yanagimoto H, Yamanaka R, Kamura T, Matsumoto T, Mine T, Yamada A,Itoh K
- Organizer
  ASCO 2008 (American Society of Clinical Oncology) Annual Meeting
- Place of Presentation
  シカゴ
- Year and Date
  2008-06-01
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] HLA-A26前列腺癌患者およびHCV感染者に対するワクチン候補ペプチドの解析2008
- Author(s)
  牛亜梅, 寺崎康展, 小松誠和, 野口正典, 七條茂樹, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-28
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] HLA-A24陽性進行癌を対象としたテーラーメイド型ペプチドワクチン療法の第I相試験および継続投与試験2008
- Author(s)
  寺崎瑞彦, 野口正典, 内藤誠二, 植村天受, 赤座英之, 渋井壮一郎, 藤巻高光, 青木友和, 伊東恭悟, 峯田寿裕, 梶原浩司
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  名古屋
- Year and Date
  2008-11-01
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 再燃前立腺癌に対するペプチドワクチン・低用量エストラムスチン併用療法と常用量エストラムスチン単独療法とのランダム化臨床比較試験2008
- Author(s)
  野口正典
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-31
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 2年以上の長期テーラーメイド型ペプチドワクチン療法を行った進行再燃前立腺癌患者の免疫学的検討2008
- Author(s)
  野口正典, 末金茂高, 守屋普久子, 山田亮, 伊東恭悟, 松岡啓
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  埼玉
- Year and Date
  2008-07-02
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for HLA-A2 positive patients with advanced cancer2008
- Author(s)
  Noguchi M
- Organizer
  ASCO 2008 (American Society of clinical Oncology) Annual Meeting
- Place of Presentation
  アメリカ(シカゴ)
- Year and Date
  2008-06-01
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] A phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients.2008
- Author(s)
  Suekane S, Noguchi M, Komohara Y, Nishitani M, Niroh M, Honma S, Yamada A, Kanayama H, Itoh K, Matuoka K
- Organizer
  第23回 EAU (European Association of Urology) Annual Meeting
- Place of Presentation
  ミラノ
- Year and Date
  2008-03-26
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] HLA-A2、-A24患者に対するペプチドワクチンとしてのHLA-A3スーパータイプペプチドの可能性2008
- Author(s)
  寺崎康展, 牛亜梅, 七條茂樹, 小松誠和, 野口正典, 藤堂省, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-28
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] テーラーメイド癌ペプチドワクチン臨床試験の生存解析:475症例でのアップデート2008
- Author(s)
  峯孝志, 野口正典, 藤堂省, 柳本泰明, 植村天受, 山中龍也, 嘉村敏治, 岡正朗, 奥野清隆, 松本和将, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-29
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for advanced cancer2008
- Author(s)
  Noguchi M, Todo S, Yanagimoto H, Yamanaka R, Oka M, Matsumoto T, Mine T, Yamada A,Matsuoka K, Itoh K
- Organizer
  UICC 2008 (International Union Against Cancer) World Cancer Congress
- Place of Presentation
  ジュネーブ
- Year and Date
  2008-08-31
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for advanced cancer2008
- Author(s)
  Noguchi M
- Organizer
  UICC 2008 (International Union Against Cancer) World Cancer Congress
- Place of Presentation
  スイス(ジュネーブ)
- Year and Date
  2008-08-30
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Phase I trial of personalized peptide vaccine for HLA-A24 positive patients with advanced cancer2008
- Author(s)
  Terasaki1 M, Noguchi1 M, Naito S, Uemura H, Akaza H, Sibui S, Fujimaki T, Aoki T, Itoh K
- Organizer
  ASCO 2008 (American Society of Clinical Oncology) Annual Meeting
- Place of Presentation
  シカゴ
- Year and Date
  2008-06-02
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients2008
- Author(s)
  Noguchi M, Suekane S, Mohamed ER, Matsuoka K
- Organizer
  第1回 ICDD (International Conference on Drug Design & Discovery)
- Place of Presentation
  ドバイ
- Year and Date
  2008-02-04
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 再燃前立腺癌に対するペプチドワクチン・低用量エストラムスチン併用療法と常用量エストラムスチン単独療法とのランダム化臨床比較試験2008
- Author(s)
  野口正典, 末金茂高, 守屋普久子, 松岡啓, 植村天受, 那須保友, 公文裕巳, 山田亮, 伊東恭悟
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Immunological and clinical effects of personalized peptide vaccine for HLA-A2 positive patients with hormone refractory prostate cancer2008
- Author(s)
  Noguchi M, Itoh K, Yamada A, Moriya F, Suekane S, Matsuoka K
- Organizer
  25Th JAPAN-KOREA UROLOGICAL CONGRESS
- Place of Presentation
  岡山
- Year and Date
  2008-09-26
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 前立腺癌に対するテーラーメイドペプチドワクチン療法の開発2007
- Author(s)
  野口正典
- Organizer
  第95回日本泌尿器科学会総会
- Place of Presentation
  神戸
- Year and Date
  2007-04-04
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 前立腺癌に対する術前テーラーメイド型ペプチドワクチン療法の抗腫瘍効果ならびに免疫応答に関する検討2007
- Author(s)
  野口正典
- Organizer
  第95回日本泌尿器科学会総会
- Place of Presentation
  神戸
- Year and Date
  2007-04-15
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] アーフーメイドペプチドワクチン多施設共同研究2007
- Author(s)
  野口正典
- Organizer
  第20回バィオセラピィ学会総会
- Place of Presentation
  札幌
- Year and Date
  2007-10-11
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 汎HLへ型テーラーメイド癌ペプチドワクチンの第1相臨床試験2007
- Author(s)
  野口正典
- Organizer
  第45回日本癌治療学会総会
- Place of Presentation
  京都
- Year and Date
  2007-10-25
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] 癌特異的免疫療法を基盤としたホルモン不応駐再燃前立腺癌に対する集学的治療2007
- Author(s)
  野口正典
- Organizer
  第59回日本泌尿器科学会西日本総会
- Place of Presentation
  松山
- Year and Date
  2007-11-08
- Data Source
  KAKENHI-PROJECT-19591877
[Presentation] Delayed PSA responses in personalized peptide vaccination for castration-resistant prostate cancer: Phase II study
- Author(s)
  Noguchi M
- Organizer
  2012 AUA Annual Meeting
- Place of Presentation
  Atolanta, USA
- Data Source
  KAKENHI-PROJECT-22591782

1. MORIYA Fukuko (80449917)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
2. Shichijo Shigeki (30080592)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
3. YAMADA Akira (50158177)

# of Collaborated Projects: 2 results

# of Collaborated Products: 12 results
4. YUTANI Shigeru (20279160)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. ITOH Kyogo (50125499)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
6. KOMATSU Masakazu (50343687)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
7. SAKAMOTO Kikuo (70279222)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. Suekane Shigetaka (40235833)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 内藤雅康 (00446080)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 山田康秀 (80290956)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 高島淳生 (20576186)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. YAMADA Satoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 笹田哲朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

NOGUCHI Masanori 野口 正典

野口 正典 ノグチ マサノリ

Research Projects

Research Products

Co-Researchers

Biomarkers of personalized peptide vaccination for metastatic upper tract urothelial carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Haptoglobin polymorphism as a prognostic biomarker for peptide vaccine efficacy in cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Genomic and epigenetic analysis for immune responses in patients with prostate cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic and clinical research on pan-HLA peptide vaccination for prostate cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

BACICALAND CLINICAL RESERCH OF PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCERPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

泌尿器系悪性腫瘍に発現する癌拒絶抗原の同定と臨床応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Next-generation peptide vaccines for advanced cancer.2013

Author(s)

Journal Title

Data Source

[Journal Article] Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.2013

Author(s)

Journal Title

Data Source

[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.2012

Author(s)

Journal Title

Data Source

[Journal Article] A novel immunotherapeutic approach for advanced cancer.2012

Author(s)

Journal Title

Data Source

[Journal Article] Personalized peptide vaccination in patients with refractory non-small cell lung cancer.2012

Author(s)

Journal Title

Data Source

[Journal Article] Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer.2012

Author(s)

Journal Title

NOGUCHI Masanori 野口正典

野口正典ノグチマサノリ